Publication

DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistance

Graph Chat

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistance

Chat with Graph Search

Further Knowledge and Developments in Resistance Mechanisms to Immune Checkpoint Inhibitors

Revisiting the specificity and ability of phospho-S129 antibodies to capture alpha-synuclein biochemical and pathological diversity

Alzheimer's drug turns macrophages against cancer

Genome-wide Screens Implicate Loss of Cullin Ring Ligase 3 in Persistent Proliferation and Genome Instability in TP53-Deficient Cells

From Patients to Platelets and Back Again: Pharmacological Approaches to Glycoprotein VI, a Thrilling Antithrombotic Target with Minor Bleeding Risks

Progestins used for hormonal contraception in Switzerland: study of their effects on the breast epithelium

Repositioning approved drugs for the treatment of problematic cancers using a screening approach

Study of transposon-mediated cell pool and cell line generation in CHO cells

Functional genomics lead to new therapies in follicular lymphoma

Activation of a glioma-specific immune response by oncolytic parvovirus Minute Virus of Mice infection

Synthesis of C-linked Disaccharides and Analogues as Biomimetics of the TF Epitope